| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 1,435,321 | 1,394,982 | 1,532,782 | 1,450,932 |
| Expenses-Medical Services | 1,489,479 | 1,445,245 | - | - |
| Expenses | - | - | 1,482,060 | 1,505,950 |
| Expenses-Other Operating | 13,488 | 2,164 | - | - |
| General and administrative | 56,198 | 56,281 | 65,956 | 63,123 |
| Depreciation and amortization | 7,430 | 7,319 | 6,876 | 6,218 |
| Total expenses | 1,566,595 | 1,511,009 | 1,554,892 | 1,584,440 |
| Income (loss) from operations | -131,274 | -116,027 | -22,110 | -133,508 |
| Income (loss) from equity method investments | 13,133 | 5,412 | 12,672 | 2,047 |
| Other income (expense), net | 9,441 | 7,879 | 9,261 | 16,061 |
| Interest expense | 1,838 | 1,572 | 1,515 | 1,622 |
| Income (loss) before income taxes | -110,538 | -104,308 | -1,692 | -117,022 |
| Income tax benefit (expense) | -331 | 62 | 196 | -590 |
| Income (loss) from continuing operations | -110,207 | -104,370 | -1,888 | -116,432 |
| Income (loss) before gain (loss) on sales | 0 | 0 | - | -1,183 |
| Adjustments on sale of assets, net | 0 | 0 | 14,000 | - |
| Total discontinued operations | 0 | 0 | 14,000 | -1,183 |
| Net income (loss) | -110,207 | -104,370 | 12,112 | -117,615 |
| Noncontrolling interests share in (earnings) loss | 0 | 0 | - | - |
| Net income (loss) attributable to common shares | -110,207 | -104,370 | 12,112 | -117,615 |
| Weighted average shares outstanding basic (in shares) | 414,465,000 | 413,836,000 | 412,936,000 | 411,591,000 |
| Weighted average shares outstanding diluted (in shares) | 414,465,000 | 413,836,000 | 412,936,000 | 411,591,000 |
agilon health, inc. (AGL)
agilon health, inc. (AGL)